TAK · Takeda Pharmaceutical Co Ltd
$17.63
+0.24 (+1.38%)
At close · Aug 14
Market Cap
$56.30B
Shares
3.19B
Takeda Pharmaceutical Co Ltd Earnings Call Transcripts
Every quarterly earnings call for Takeda Pharmaceutical Co Ltd (TAK) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY27 · Q1
2026-07-30
Earnings conference call (announced in 6-K)
Confident tone
Product launches (Ova-Parexidon, Rusphotide, Zasocytinib)
Horizon 1 vs Horizon 2 growth strategy
Core inline brand resiliency (Antivio, GammaGuard)
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q3
2026-01-29
Earnings conference call (announced in 6-K)
Confident tone
Product Launches (Ova-Parexidon, Rusphotide, Zasocytinib)
Horizon 1 / Horizon 2 Growth Framework
Core Inline Brands Resilience
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2022-12-31
Takeda Pharmaceutical Co Ltd Q3 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–3 of 3 earnings calls